BACKGROUND: Although brucellosis (Brucella spp.) and Q Fever (Coxiella burnetii) are zoonoses of global importance, very little high quality data are available from West Africa. METHODS/PRINCIPAL FINDINGS: A serosurvey was conducted in Togo's main livestock-raising zone in 2011 in 25 randomly selected villages, including 683 people, 596 cattle, 465 sheep and 221 goats. Additionally, 464 transhumant cattle from Burkina Faso were sampled in 2012. The serological analyses performed were the Rose Bengal Test and ELISA for brucellosis and ELISA and the immunofluorescence assay (IFA) for Q Fever Brucellosis did not appear to pose a major human health problem in the study zone, with only 7 seropositive participants. B. abortus was isolated from 3 bovine hygroma samples, and is likely to be the predominant circulating strain. This may explain the observed seropositivity amongst village cattle (9.2%, 95%CI:4.3-18.6%) and transhumant cattle (7.3%, 95%CI:3.5-14.7%), with an absence of seropositive small ruminants. Exposure of livestock and people to C. burnetii was common, potentially influenced by cultural factors. People of Fulani ethnicity had greater livestock contact and a significantly higher seroprevalence than other ethnic groups (Fulani: 45.5%, 95%CI:37.7-53.6%; non-Fulani: 27.1%, 95%CI:20.6-34.7%). Appropriate diagnostic test cut-off values in endemic settings requires further investigation. Both brucellosis and Q Fever appeared to impact on livestock production. Seropositive cows were more likely to have aborted a foetus during the previous year than seronegative cows, when adjusted for age. This odds was 3.8 times higher (95%CI: 1.2-12.1) for brucellosis and 6.7 times higher (95%CI: 1.3-34.8) for Q Fever. CONCLUSIONS: This is the first epidemiological study of zoonoses in Togo in linked human and animal populations, providing much needed data for West Africa. Exposure to Brucella and C. burnetii is common but further research is needed into the clinical and economic impact.
BACKGROUND: Although brucellosis (Brucella spp.) and Q Fever (Coxiella burnetii) are zoonoses of global importance, very little high quality data are available from West Africa. METHODS/PRINCIPAL FINDINGS: A serosurvey was conducted in Togo's main livestock-raising zone in 2011 in 25 randomly selected villages, including 683 people, 596 cattle, 465 sheep and 221 goats. Additionally, 464 transhumant cattle from Burkina Faso were sampled in 2012. The serological analyses performed were the Rose Bengal Test and ELISA for brucellosis and ELISA and the immunofluorescence assay (IFA) for Q Fever Brucellosis did not appear to pose a major human health problem in the study zone, with only 7 seropositive participants. B. abortus was isolated from 3 bovinehygroma samples, and is likely to be the predominant circulating strain. This may explain the observed seropositivity amongst village cattle (9.2%, 95%CI:4.3-18.6%) and transhumant cattle (7.3%, 95%CI:3.5-14.7%), with an absence of seropositive small ruminants. Exposure of livestock and people to C. burnetii was common, potentially influenced by cultural factors. People of Fulani ethnicity had greater livestock contact and a significantly higher seroprevalence than other ethnic groups (Fulani: 45.5%, 95%CI:37.7-53.6%; non-Fulani: 27.1%, 95%CI:20.6-34.7%). Appropriate diagnostic test cut-off values in endemic settings requires further investigation. Both brucellosis and Q Fever appeared to impact on livestock production. Seropositive cows were more likely to have aborted a foetus during the previous year than seronegative cows, when adjusted for age. This odds was 3.8 times higher (95%CI: 1.2-12.1) for brucellosis and 6.7 times higher (95%CI: 1.3-34.8) for Q Fever. CONCLUSIONS: This is the first epidemiological study of zoonoses in Togo in linked human and animal populations, providing much needed data for West Africa. Exposure to Brucella and C. burnetii is common but further research is needed into the clinical and economic impact.
Authors: G J Blaauw; D W Notermans; B Schimmer; J Meekelenkamp; J H J Reimerink; P Teunis; P M Schneeberger Journal: Epidemiol Infect Date: 2011-02-15 Impact factor: 2.451
Authors: Myrna M T de Rooij; Barbara Schimmer; Bart Versteeg; Peter Schneeberger; Boyd R Berends; Dick Heederik; Wim van der Hoek; Inge M Wouters Journal: PLoS One Date: 2012-02-21 Impact factor: 3.240
Authors: Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas Journal: PLoS Med Date: 2007-12 Impact factor: 11.069
Authors: Akwoba Joseph Ogugua; Victor Oluwatoyin Akinseye; Eniola O Cadmus; Emmanuel A Jolaoluwa Awosanya; Peter Ibukun Alabi; Olugbenga S Idowu; Samson A Akinade; Emma J Dale; Lorraine Perrett; Andrew Taylor; Moriyon Ignocio; Simeon I B Cadmus Journal: Trop Anim Health Prod Date: 2018-04-22 Impact factor: 1.559
Authors: Eveline A Germeraad; Lenny Hogerwerf; Tisbeh Faye-Joof; Bart Goossens; Wim van der Hoek; Momodou Jeng; Modou Lamin; Ismaila L Manneh; Davis Nwakanma; Hendrik I J Roest; Arss Secka; Arjan Stegeman; Rita Wegmüller; Marianne A B van der Sande; Ousman Secka Journal: PLoS One Date: 2016-11-08 Impact factor: 3.240
Authors: J Njeru; K Henning; M W Pletz; R Heller; C Forstner; S Kariuki; E M Fèvre; H Neubauer Journal: BMC Infect Dis Date: 2016-06-03 Impact factor: 3.090
Authors: Eric Mogaka Osoro; Peninah Munyua; Sylvia Omulo; Eric Ogola; Fredrick Ade; Peter Mbatha; Murithi Mbabu; Zipporah Ng'ang'a; Salome Kairu; Marybeth Maritim; Samuel M Thumbi; Austine Bitek; Stella Gaichugi; Carol Rubin; Kariuki Njenga; Marta Guerra Journal: Am J Trop Med Hyg Date: 2015-06-22 Impact factor: 2.345
Authors: C Mathew; M Stokstad; T B Johansen; S Klevar; R H Mdegela; G Mwamengele; P Michel; L Escobar; D Fretin; J Godfroid Journal: BMC Vet Res Date: 2015-07-21 Impact factor: 2.741